It is one of the largest pharmaceutical companies and the owner of the world's current best-selling drug, cancer medicine ...

Merck will discontinue its antibody-drug Zinplava for a bacterial infection that can lead to fatal diarrhea, according to the ...

The global market for community acquired bacterial pneumonia (CABP) treatment is expected to experience robust growth over ...

Shares of Merck & Co. Inc. MRK inched 0.08% higher to $99.45 Tuesday, on what proved to be an all-around favorable trading ...

A Fremont pharmaceutical company received an investment of approximately $50 million — about $3.56 per share — in a private ...

Latest DJIA performance as of December 24, 2024, including key stock movements, market trends & insights into the economic ...

According to the WHO, the proportion of the world’s population aged over 60 years will almost double, from 12% to 22%, ...

Treatment Market. According to a recent market analysis conducted by Future Market Insights, the global molluscum contagiosum ...

Merck will discontinue its drug for a bacterial infection that can lead to fatal diarrhea, the U.S. Food and Drug ...

Women with gestational hypertension and preeclampsia had about 1% incidence of a new-onset neurologic disorder 4 years after ...

On Friday, Merck & Co Inc (MRK) stock saw a decline, ending the day at $98.05 which represents a decrease of $-1.47 or -1.48% from the prior close of $99.52. The stock opened at $98.83 and touched a ...

The phase III SOUND trial randomized patients with early breast cancer and a negative axillary ultrasound to SLNB or no ...